|
1
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song
J, Zhao X, Huang B, Shi W, Lu R, et al: A novel coronavirus from
patients with pneumonia in China, 2019. N Engl J Med. 382:727–733.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Worldometer. COVID-19 Coronavirus
Pandemic. Dover, Delaware: uriWorldometers.infosimpleWorldometers.info., 2020
Available online at: uriwww.worldometers.info/coronavirussimplewww.worldometers.info/coronavirus
(accessed August 28, 2020).
|
|
3
|
Andersen KG, Rambaut A, Lipkin WI, Holmes
EC and Garry RF: The proximal origin of SARS-CoV-2. Nat Med.
26:450–452. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Contini C, Di Nuzzo M, Barp N, Bonazza A,
De Giorgio R, Tognon M and Rubino S: The novel zoonotic COVID-19
pandemic: An expected global health concern. J Infect Dev Ctries.
14:254–264. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Prada V, Benedetti L, Cocito D, Briani C,
Orazio EN, Gallia F, Antonini G, Manganelli F, Fabrizi GM, Germano
F, et al: High-dose immunoglobulin pulse therapy and risk of
Covid19 infection. J Neurol. 1–3. 2020.doi:
10.1007/s00415-020-10146-5 (Epub ahead of print). PubMed/NCBI View Article : Google Scholar
|
|
6
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ahmed SS: The coronavirus disease 2019
(COVID-19): A review. J Adv Med Med Res 32: 1-9, 2020.
|
|
8
|
Grant WB, Lahore H, McDonnell SL, Baggerly
CA, French CB, Aliano JL and Bhattoa HP: Evidence that vitamin D
supplementation could reduce risk of influenza and COVID-19
infections and deaths. Nutrients. 12(988)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang L and Liu Y: Potential interventions
for novel coronavirus in China: A systematic review. J Med Virol.
92:479–490. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang R, Wang X, Ni L, Di X, Ma B, Niu S,
Liu C and Reiter RJ: COVID-19: Melatonin as a potential adjuvant
treatment. Life Sci. 250(117583)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ang L, Lee HW, Kim A, Lee JA, Zhang J and
Lee MS: Herbal medicine for treatment of children diagnosed with
COVID-19: A review of guidelines. Complement Ther Clin Pract.
39(101174)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Islam MT, Sarkar C, El-Kersh DM, Jamaddar
S, Uddin SJ, Shilpi JA and Mubarak MS: Natural products and their
derivatives against coronavirus: A review of the non-clinical and
pre-clinical data. Phytother Res: Apr 4, 2020 doi: 10.1002/ptr.6700
(Epub ahead of print).
|
|
13
|
Yu MS, Lee J, Lee JM, Kim Y, Chin YW, Jee
JG, Keum YS and Jeong YJ: Identification of myricetin and
scutellarein as novel chemical inhibitors of the SARS coronavirus
helicase, nsP13. Bioorg Med Chem Lett. 22:4049–4054.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ashour HM, Elkhatib WF, Rahman MM and
Elshabrawy HA: Insights into the recent 2019 novel Coronavirus
(SARS-CoV-2) in light of past human coronavirus outbreaks.
Pathogens. 9(186)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chandrasekharan JA, Marginean A and
Sharma-Walia N: An insight into the role of arachidonic acid
derived lipid mediators in virus associated pathogenesis and
malignancies. Prostaglandins Other Lipid Mediat. 126:46–54.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Innes JK and Calder PC: Omega-6 fatty
acids and inflammation. Prostaglandins Leukot Essent Fatty Acids.
132:41–48. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Duvall MG and Levy BD: DHA- and
EPA-derived resolvins, protectins, and maresins in airway
inflammation. Eur J Pharmacol. 785:144–155. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chiurchiù V, Leuti A, Dalli J, Jacobsson
A, Battistini L, Maccarrone M and Serhan CN: Proresolving lipid
mediators resolvin D1, resolvin D2, and maresin 1 are critical in
modulating T cell responses. Sci Transl Med.
8(353ra111)2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ramsden CE: Breathing easier with fish
oil-a new approach to preventing asthma? N Engl J Med.
375:2596–2598. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Das UN: Can bioactive lipids inactivate
coronavirus (COVID-19)? Arch Med Res. 51:282–286. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Velavan TP and Meyer CG: The COVID-19
epidemic. Trop Med Int Health. 25:278–280. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Victor A: Mathematical predictions for
COVID-19 as a global pandemic. Available at SSRN 3555879, 2020.
|
|
23
|
McCartney DM and Byrne DG: Optimisation of
Vitamin D status for enhanced immuno-protection against Covid-19.
Ir Med J. 113(58)2020.PubMed/NCBI
|
|
24
|
Yalaki Z, Taşar MA, Oney H and Gokceoğlu
AU: Comparison of viral agents and Vitamin D levels in children
with acute bronchiolitis infection. J Pediatr Inf. 13:e14–e20.
2019.
|
|
25
|
Larkin A and Lassetter J: Vitamin D
deficiency and acute lower respiratory infections in children
younger than 5 years: Identification and treatment. J Pediatr
Health Care. 28:572–582. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Loeb M, Dang AD, Thiem VD, Thanabalan V,
Wang B, Nguyen NB, Tran HTM, Luong TM, Singh P, Smieja M, et al:
Effect of Vitamin D supplementation to reduce respiratory
infections in children and adolescents in Vietnam: A randomized
controlled trial. Influenza Other Respir Viruses. 13:176–183.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hemilä H and Chalker E: Vitamin C may
reduce the duration of mechanical ventilation in critically ill
patients: A meta-regression analysis. J Intensive Care.
8(15)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hemilä H: Vitamin C and common
cold-induced asthma: A systematic review and statistical analysis.
Allergy Asthma Clin Immunol. 9(46)2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jeong YJ, Kim JH, Kang JS, Lee WJ and
Hwang YI: Mega-dose vitamin C attenuated lung inflammation in mouse
asthma model. Anat Cell Biol. 43:294–302. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wiesner-Reinhold M, Schreiner M,
Baldermann S, Schwarz D, Hanschen FS, Kipp AP, Rowan DD,
Bentley-Hewitt KL and McKenzie MJ: Mechanisms of selenium
enrichment and measurement in brassicaceous vegetables, and their
application to human health. Front Plant Sci.
8(1365)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Guillin OM, Vindry C, Ohlmann T and
Chavatte L: Selenium, selenoproteins and viral infection.
Nutrients. 11(2101)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Xu J, Gong Y, Sun Y, Cai J, Liu Q, Bao J,
Yang J and Zhang Z: Impact of selenium deficiency on inflammation,
oxidative stress, and phagocytosis in mouse macrophages. Biol Trace
Elem Res. 194:237–243. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Harthill M: Micronutrient selenium
deficiency influences evolution of some viral infectious diseases.
Biol Trace Elem Res. 143:1325–1336. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yu L, Sun L, Nan Y and Zhu LY: Protection
from H1N1 influenza virus infections in mice by supplementation
with selenium: A comparison with selenium-deficient mice. Biol
Trace Elem Res. 141:254–261. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li Y, Lin Z, Guo M, Zhao M, Xia Y, Wang C,
Xu T and Zhu B: Inhibition of H1N1 influenza virus-induced
apoptosis by functionalized selenium nanoparticles with amantadine
through ROS-mediated AKT signaling pathways. Int J Nanomedicine.
13:2005–2016. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Li Y, Lin Z, Gong G, Guo M, Xu T, Wang C,
Zhao M, Xia Y, Tang Y, Zhong J, et al: Inhibition of H1N1 influenza
virus-induced apoptosis by selenium nanoparticles functionalized
with arbidol through ROS-mediated signaling pathways. J Mater Chem
B Mater Biol Med. 7:4252–4262. 2019.
|
|
37
|
Kieliszek M and Lipinski B: Selenium
supplementation in the prevention of coronavirus infections
(COVID-19). Med Hypotheses. 143(109878)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wessels I, Maywald M and Rink L: Zinc as a
gatekeeper of immune function. Nutrients. 9(1286)2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Pae M and Wu D: Nutritional modulation of
age-related changes in the immune system and risk of infection.
Nutr Res. 41:14–35. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Barnett JB, Hamer DH and Meydani SN: Low
zinc status: A new risk factor for pneumonia in the elderly? Nutr
Rev. 68:30–37. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Walker CLF, Rudan I, Liu L, Nair H,
Theodoratou E, Bhutta ZA, O'Brien KL, Campbell H and Black RE:
Global burden of childhood pneumonia and diarrhoea. Lancet.
381:1405–1416. 2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kumar NS, Jayaprakash S and Kavitha D: Low
serum Zinc level-a possible Marker of severe pneumonia. J Med Sci
Clin Res. 5:21554–21570. 2017.
|
|
43
|
Shah UH, Abu-Shaheen AK, Malik MA, Alam S,
Riaz M and Al-Tannir MA: The efficacy of zinc supplementation in
young children with acute lower respiratory infections: A
randomized double-blind controlled trial. Clin Nutr. 32:193–199.
2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Suara RO and Crowe JE: Effect of zinc
salts on respiratory syncytial virus replication. Antimicrob Agents
Chemother. 48:783–790. 2004.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Truong-Tran AQ, Carter J, Ruffin R and
Zalewski PD: New insights into the role of zinc in the respiratory
epithelium. Immunol Cell Biol. 79:170–177. 2001.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Roscioli E, Jersmann HP, Lester S, Badiei
A, Fon A, Zalewski P and Hodge S: Zinc deficiency as a
codeterminant for airway epithelial barrier dysfunction in an ex
vivo model of COPD. Int J Chron Obstruct Pulmon Dis. 12:3503–3510.
2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Darma A, Athiyyah AF, Ranuh RG, Merbawani
W, Setyoningrum RA, Hidajat B, Hidayati SN, Endaryanto A and
Sudarmo SM: Zinc Supplementation effect on the bronchial cilia
length, the number of cilia, and the number of intact bronchial
cell in Zinc deficiency rats. Indones Biomed J. 12:78–84. 2020.
|
|
48
|
Woodworth BA, Zhang S, Tamashiro E,
Bhargave G, Palmer JN and Cohen NA: Zinc increases ciliary beat
frequency in a calcium-dependent manner. Am J Rhinol Allergy.
24:6–10. 2010.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Te Velthuis AJ, van den Worm SH, Sims AC,
Baric RS, Snijder EJ and van Hemert MJ: Zn(2+) inhibits coronavirus
and arterivirus RNA polymerase activity in vitro and zinc
ionophores block the replication of these viruses in cell culture.
PLoS Pathog. 6(e1001176)2010.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Kumar A, Kubota Y, Chernov M and Kasuya H:
Potential role of Zinc supplementation in prophylaxis and treatment
of COVID-19. Med Hypotheses. 144(109848)2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wessling-Resnick M: Crossing the Iron
gate: Why and how transferrin receptors mediate viral entry. Annu
Rev Nutr. 38:431–458. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Ali MK, Kim RY, Karim R, Mayall JR, Martin
KL, Shahandeh A, Abbasian F, Starkey MR, Loustaud-Ratti V,
Johnstone D, et al: Role of iron in the pathogenesis of respiratory
disease. Int J Biochem Cell Biol. 88:181–195. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Jayaweera JAAS, Reyes M and Joseph A:
Childhood iron deficiency anemia leads to recurrent respiratory
tract infections and gastroenteritis. Sci Rep.
9(12637)2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Homma S, Azuma A, Taniguchi H, Ogura T,
Mochiduki Y, Sugiyama Y, Nakata K, Yoshimura K, Takeuchi M and
Kudoh S: Japan NAC Clinical Study Group: Efficacy of inhaled
N-acetylcysteine monotherapy in patients with early stage
idiopathic pulmonary fibrosis. Respirology. 17:467–477.
2012.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Blasi F, Page C, Rossolini GM, Pallecchi
L, Matera MG, Rogliani P and Cazzola M: The effect of
N-acetylcysteine on biofilms: Implications for the treatment of
respiratory tract infections. Respir Med. 117:190–197.
2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Cazzola M, Calzetta L, Page C, Jardim J,
Chuchalin AG, Rogliani P and Matera MG: Influence of
N-acetylcysteine on chronic bronchitis or COPD exacerbations: A
meta-analysis. Eur Respir Rev. 24:451–461. 2015.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Santus P, Corsico A, Solidoro P, Braido F,
Di Marco F and Scichilone N: Oxidative stress and respiratory
system: Pharmacological and clinical reappraisal of
N-acetylcysteine. COPD. 11:705–717. 2014.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Mata M, Sarrion I, Armengot M, Carda C,
Martinez I, Melero JA and Cortijo J: Respiratory syncytial virus
inhibits ciliagenesis in differentiated normal human bronchial
epithelial cells: Effectiveness of N-acetylcysteine. PLoS One.
7(e48037)2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Sadowska AM: N-Acetylcysteine mucolysis in
the management of chronic obstructive pulmonary disease. Ther Adv
Respir Dis. 6:127–135. 2012.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Andreou A, Trantza S, Filippou D, Sipsas N
and Tsiodras S: COVID-19: The potential role of copper and
N-acetylcysteine (NAC) in a combination of candidate antiviral
treatments against SARS-CoV-2. In Vivo. 34:1567–1588.
2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Jaiswal N, Bhatnagar M and Shah H:
N-acetycysteine: A potential therapeutic agent in COVID-19
infection. Med Hypotheses. 144(110133)2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ohtake S, Arakawa T and Koyama AH:
Arginine as a synergistic virucidal agent. Molecules. 15:1408–1424.
2010.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Meingast C and Heldt CL:
Arginine-enveloped virus inactivation and potential mechanisms.
Biotechnol Prog. 36(e2931)2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Tsujimoto K, Uozaki M, Ikeda K, Yamazaki
H, Utsunomiya H, Ichinose M, Koyama AH and Arakawa T:
Solvent-induced virus inactivation by acidic arginine solution. Int
J Mol Med. 25:433–437. 2010.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Yamasaki H, Tsujimoto K, Koyama AH, Ejima
D and Arakawa T: Arginine facilitates inactivation of enveloped
viruses. J Pharm Sci. 97:3067–3073. 2008.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Ikeda K, Yamasaki H, Minami S, Suzuki Y,
Tsujimoto K, Sekino Y, Irie H, Arakawa T and Koyama AH: Arginine
inactivates human herpesvirus 2 and inhibits genital herpesvirus
infection. Int J Mol Med. 30:1307–1312. 2012.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Ikeda K, Yamasaki H, Suzuki Y, Koyama AH
and Arakawa T: Novel strategy with acidic arginine solution for the
treatment of influenza A virus infection. Exp Ther Med. 1:251–256.
2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Zhang R, Kubo M, Murakami I, Setiawan H,
Takemoto K, Inoue K, Fujikura Y and Ogino K: l-Arginine
administration attenuates airway inflammation by altering
l-arginine metabolism in an NC/Nga mouse model of asthma. J Clin
Biochem Nutr. 56:201–207. 2015.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Pierre JF, Heneghan AF, Lawson CM,
Wischmeyer PE, Kozar RA and Kudsk KA: Pharmaconutrition review:
Physiological mechanisms. JPEN J Parenter Enteral Nutr. 37 (5
Suppl):51S–65S. 2013.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Lee CH, Kim HK, Kim JM, Ayush O, Im SY, Oh
DK and Lee HK: Glutamine suppresses airway neutrophilia by blocking
cytosolic phospholipase A(2) via an induction of MAPK
phosphatase-1. J Immunol. 189:5139–5146. 2012.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Lai CC, Liu WL and Chen CM: Glutamine
attenuates acute lung injury caused by acid aspiration. Nutrients.
6:3101–3116. 2014.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Oliveira GP, De Abreu MG, Pelosi P and
Rocco PR: Exogenous glutamine in respiratory diseases: Myth or
reality? Nutrients. 8(76)2016.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Romano L, Bilotta F, Dauri M, Macheda S,
Pujia A, De Santis GL, Tarsitano MG, Merra G, Di Renzo L, Esposito
E and De Lorenzo A: Short report-medical nutrition therapy for
critically ill patients with COVID-19. Eur Rev Med Pharmacol Sci.
24:4035–4039. 2020.PubMed/NCBI View Article : Google Scholar
|
|
74
|
West NP, Horn PL, Pyne DB, Gebski VJ,
Lahtinen SJ, Fricker PA and Cripps AW: Probiotic supplementation
for respiratory and gastrointestinal illness symptoms in healthy
physically active individuals. Clin Nutr. 33:581–587.
2014.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Maldonado J, Cañabate F, Sempere L, Vela
F, Sánchez AR, Narbona E, López-Huertas E, Geerlings A, Valero AD,
Olivares M and Lara-Villoslada F: Human milk probiotic
Lactobacillus fermentum CECT5716 reduces the incidence of
gastrointestinal and upper respiratory tract infections in infants.
J Pediatr Gastroenterol Nutr. 54:55–61. 2012.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Ozen M, Kocabas Sandal G and Dinleyici EC:
Probiotics for the prevention of pediatric upper respiratory tract
infections: A systematic review. Expert Opin Biol Ther. 15:9–20.
2015.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Strasser B, Geiger D, Schauer M, Gostner
JM, Gatterer H, Burtscher M and Fuchs D: Probiotic supplements
beneficially affect tryptophan-kynurenine metabolism and reduce the
incidence of upper respiratory tract infections in trained
athletes: A randomized, double-blinded, placebo-controlled trial.
Nutrients. 8(752)2016.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hor YY, Lew LC, Lau ASY, Ong JS, Chuah LO,
Lee YY, Choi SB, Rashid F, Wahid N, Sun Z, et al: Probiotic
Lactobacillus casei Zhang (LCZ) alleviates respiratory,
gastrointestinal & RBC abnormality via immuno-modulatory,
anti-inflammatory & anti-oxidative actions. J Funct Foods.
44:235–245. 2018.
|
|
79
|
Kitazawa H and Villena J: Modulation of
respiratory TLR3-anti-viral response by probiotic microorganisms:
Lessons learned from Lactobacillus rhamnosus CRL1505. Front
Immunol. 5(201)2014.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Eguchi K, Fujitani N, Nakagawa H and
Miyazaki T: Prevention of respiratory syncytial virus infection
with probiotic lactic acid bacterium Lactobacillus gasseri
SBT2055. Sci Rep. 9(4812)2019.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Kang EJ, Kim SY, Hwang IH and Ji YJ: The
effect of probiotics on prevention of common cold: A meta-analysis
of randomized controlled trial studies. Korean J Fam Med. 34:2–10.
2013.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Mak JWY, Chan FKL and Ng SC: Probiotics
and COVID-19: One size does not fit all. Lancet Gastroenterol
Hepatol. 5:644–645. 2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Jayawardena R, Sooriyaarachchi P,
Chourdakis M, Jeewandara C and Ranasinghe P: Enhancing immunity in
viral infections, with special emphasis on COVID-19: A review.
Diabetes Metab Syndr. 14:367–382. 2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Morais AHA, Passos TS, Maciel BLL and da
Silva-Maia JK: Can probiotics and diet promote beneficial immune
modulation and purine control in coronavirus infection? Nutrients.
12(1737)2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Infusino F, Marazzato M, Mancone M, Fedele
F, Mastroianni CM, Severino P, Ceccarelli G, Santinelli L,
Cavarretta E, Marullo AGM, et al: Diet supplementation, probiotics,
and Nutraceuticals in SARS-CoV-2 infection: A scoping review.
Nutrients. 12(1718)2020.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Baud D, Agri VD, Gibson GR, Reid G and
Giannoni E: Using probiotics to flatten the curve of coronavirus
disease COVID-2019 pandemic. Front Public Health.
8(186)2020.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Ibarguren M, López DJ and Escribá PV: The
effect of natural and synthetic fatty acids on membrane structure,
microdomain organization, cellular functions and human health.
Biochim Biophys Acta. 1838:1518–1528. 2014.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Thom G and Lean M: Is there an optimal
diet for weight management and metabolic health? Gastroenterology.
152:1739–1751. 2017.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Lemoine S CM, Brigham EP, Woo H, Hanson
CK, McCormack MC, Koch A, Putcha N and Hansel NN: Omega-3 fatty
acid intake and prevalent respiratory symptoms among U.S. adults
with COPD. BMC Pulm Med. 19(97)2019.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Escamilla-Nuñez MC, Barraza-Villarreal A,
Hernández-Cadena L, Navarro-Olivos E, Sly PD and Romieu I: Omega-3
fatty acid supplementation during pregnancy and respiratory
symptoms in children. Chest. 146:373–382. 2014.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Singer P and Shapiro H: Enteral omega-3 in
acute respiratory distress syndrome. Curr Opin Clin Nutr Metab
Care. 12:123–128. 2009.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Abidi A, Kourda N, Feki M and Ben Khamsa
S: Protective effect of Tunisian flaxseed oil against
bleomycin-induced pulmonary fibrosis in rats. Nutr Cancer.
72:226–238. 2020.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Whyand T, Hurst JR, Beckles M and Caplin
ME: Pollution and respiratory disease: Can diet or supplements
help? A review. Respir Res. 19(79)2018.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Knapp HR: Omega-3 fatty acids in
respiratory diseases: A review. J Am Coll Nutr. 14:18–23.
1995.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Miyata J and Arita M: Role of omega-3
fatty acids and their metabolites in asthma and allergic diseases.
Allergol Int. 64:27–34. 2015.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Yates CM, Calder PC and Rainger GE:
Pharmacology and therapeutics of omega-3 polyunsaturated fatty
acids in chronic inflammatory disease. Pharmacol Ther. 141:272–282.
2014.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Morita M, Kuba K, Ichikawa A, Nakayama M,
Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S,
et al: The lipid mediator protectin D1 inhibits influenza virus
replication and improves severe influenza. Cell. 153:112–125.
2013.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Linday LA, Shindledecker RD, Tapia-Mendoza
J and Dolitsky JN: Effect of daily cod liver oil and a
multivitamin-mineral supplement with selenium on upper respiratory
tract pediatric visits by young, inner-city, Latino children:
Randomized pediatric sites. Ann Otol Rhinol Laryngol. 113:891–901.
2004.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Da Boit M, Gabriel BM, Gray P and Gray SR:
The effect of fish oil, vitamin D and protein on URTI incidence in
young active people. Int J Sports Med. 36:426–430. 2015.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Philpott JD, Witard OC and Galloway SD:
Applications of omega-3 polyunsaturated fatty acid supplementation
for sport performance. Res Sports Med. 27:219–237. 2019.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Langlois PL, D'Aragon F, Hardy G and
Manzanares W: Omega-3 polyunsaturated fatty acids in critically ill
patients with acute respiratory distress syndrome: A systematic
review and meta-analysis. Nutrition. 61:84–92. 2019.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Calder PC: Omega-3 fatty acids and
inflammatory processes: From molecules to man. Biochem Soc Trans.
45:1105–1115. 2017.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Imai Y: Role of omega-3 PUFA-derived
mediators, the protectins, in influenza virus infection. Biochim
Biophys Acta. 1851:496–502. 2015.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Messina G, Polito R, Monda V, Cipolloni L,
Di Nunno N, Di Mizio G, Murabito P, Carotenuto M, Messina A,
Pisanelli D, et al: Functional role of dietary intervention to
improve the outcome of COVID-19: A hypothesis of work. Int J Mol
Sci. 21(3104)2020.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Hammock BD, Wang W, Gilligan MM and
Panigrahy D: Eicosanoids: The overlooked storm in COVID-19? Am J
Pathol. 190:1782–1788. 2020.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Torrinhas RS, Calder PC, Lemos GO and
Waitzberg DL: Parenteral fish oil, an adjuvant pharmacotherapy for
COVID-19? Nutrition. 81(110900)2020.PubMed/NCBI View Article : Google Scholar
|
|
107
|
De Marco Castro E, Calder PC and Roche HM:
β-1,3/1,6-glucans and immunity: State of the art and future
directions. Mol Nutr Food Res. (e1901071)2020.doi:
10.1002/mnfr.201901071 (Epub ahead of print).
|
|
108
|
Murphy EA, Davis JM, Brown AS, Carmichael
MD, Carson JA, Van Rooijen N, Ghaffar A and Mayer EP: Benefits of
oat β-glucan on respiratory infection following exercise stress:
Role of lung macrophages. Am J Physiol Regul Integr Comp Physiol.
294:R1593–R1599. 2008.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Dharsono T, Rudnicka K, Wilhelm M and
Schoen C: Effects of yeast (1,3)-(1,6)-beta-glucan on severity of
upper respiratory tract infections: a double-blind, randomized,
placebo-controlled study in healthy subjects. J Am Coll Nutr.
38:40–50. 2019.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Jesenak M, Urbancikova I and Banovcin P:
Respiratory tract infections and the role of biologically active
polysaccharides in their management and prevention. Nutrients.
9(779)2017.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Talbott S and Talbott J: Effect of BETA 1,
3/1, 6 GLUCAN on upper respiratory tract infection symptoms and
mood state in marathon athletes. J Sports Sci Med. 8:509–515.
2009.PubMed/NCBI
|
|
112
|
Urbancikova I, Hudackova D, Majtan J,
Rennerova Z, Banovcin P and Jesenak M: Efficacy of Pleuran
(β-Glucan from Pleurotus ostreatus) in the management of
herpes simplex virus type 1 infection. Evid Based Complement
Alternat Med. 2020(8562309)2020.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Murphy EA, Davis JM, Brown AS, Carmichael
MD, Ghaffar A and Mayer EP: Effects of oat β-glucan on the
macrophage cytokine response to herpes simplex virus 1 infection in
vitro. J Interferon Cytokine Res. 32:362–367. 2012.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Muramatsu D, Iwai A, Aoki S, Uchiyama H,
Kawata K, Nakayama Y, Nikawa Y, Kusano K, Okabe M and Miyazaki T:
β-glucan derived from Aureobasidium pullulans is effective
for the prevention of influenza in mice. PLoS One.
7(e41399)2012.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Vetvicka V and Vetvickova J: Glucan
supplementation enhances the immune response against an influenza
challenge in mice. Ann Transl Med. 3(22)2015.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Geller A and Yan J: Could the induction of
trained immunity by β-Glucan serve as a defense against COVID-19?
Front Immunol. 11(1782)2020.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Murphy EJ, Masterson C, Rezoagli E,
O'Toole D, Major I, Stack GD, Lynch M, Laffey JG and Rowan NJ:
β-Glucan extracts from the same edible shiitake mushroom Lentinus
edodes produce differential in-vitro immunomodulatory and pulmonary
cytoprotective effects-Implications for coronavirus disease
(COVID-19) immunotherapies. Sci Total Environ.
732(139330)2020.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Singh S, Sharma B, Kanwar SS and Kumar A:
Lead phytochemicals for anticancer drug development. Front Plant
Sci. 7(1667)2016.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Altemimi A, Lakhssassi N, Baharlouei A,
Watson DG and Lightfoot DA: Phytochemicals: Extraction, isolation,
and identification of bioactive compounds from plant extracts.
Plants. 6(42)2017.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Prasanna G, Ujwal A, Diliprajudominic S,
Marimuthu T and Saraswathi NT: A new pipeline to discover
antimycotics by inhibiting ergosterol and riboflavin synthesis: The
inspirations of Siddha medicine. Med Chem Res. 23:2651–2658.
2014.
|
|
121
|
Oliveira AF, Teixeira RR, Oliveira ASD,
Souza AP, Silva MLD and Paula SO: Potential Antivirals: Natural
products targeting replication enzymes of dengue and chikungunya
viruses. Molecules. 22(505)2017.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Lin LT, Hsu WC and Lin CC: Antiviral
natural products and herbal medicines. J Tradit Complement Med.
4:24–35. 2014.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Cheng PW, Ng LT, Chiang LC and Lin CC:
Antiviral effects of saikosaponins on human coronavirus 229E in
vitro. Clin Exp Pharmacol Physiol. 33:612–616. 2006.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Lau KM, Lee KM, Koon CM, Cheung CS, Lau
CP, Ho HM, Lee MY, Au SW, Cheng CH, Lau CB, et al: Immunomodulatory
and anti-SARS activities of Houttuynia cordata. J
Ethnopharmacol. 118:79–85. 2008.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Maree JE and Viljoen AM: Phytochemical
distinction between Pelargonium sidoides and Pelargonium
reniforme-A quality control perspective. S Afr J Bot. 82:83–91.
2012.
|
|
126
|
Careddu D and Pettenazzo A: Pelargonium
sidoides extract EPs 7630: A review of its clinical efficacy
and safety for treating acute respiratory tract infections in
children. Int J Gen Med. 11:91–98. 2018.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Baars EW, Zoen EBV, Breitkreuz T, Martin
D, Matthes H, von Schoen-Angerer T, Soldner G, Vagedes J, van
Wietmarschen H, Patijn O, et al: The contribution of complementary
and alternative medicine to reduce antibiotic use: A narrative
review of health concepts, prevention, and treatment strategies.
Evid Based Complement Alternat Med. 2019(5365608)2019.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Michaelis M, Doerr HW and Cinatl J Jr:
Investigation of the influence of EPs® 7630, a herbal
drug preparation from Pelargonium sidoides, on replication
of a broad panel of respiratory viruses. Phytomedicine. 18:384–386.
2011.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Fiore C, Eisenhut M, Krausse R, Ragazzi E,
Pellati D, Armanini D and Bielenberg J: Antiviral effects of
Glycyrrhiza species. Phytother Res. 22:141–148.
2008.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Feng Yeh C, Wang KC, Chiang LC, Shieh DE,
Yen MH and San Chang J: Water extract of licorice had anti-viral
activity against human respiratory syncytial virus in human
respiratory tract cell lines. J Ethnopharmacol. 148:466–473.
2013.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Ahmad A, Husain A, Mujeeb M, Khan SA,
Najmi AK, Siddique NA, Damanhouri ZA and Anwar F: A review on
therapeutic potential of Nigella sativa: A miracle herb.
Asian Pac J Trop Biomed. 3:337–352. 2013.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Dajani EZ, Shahwan TG and Dajani NE:
Overview of the preclinical pharmacological properties of
Nigella sativa (black seeds): A complementary drug with
historical and clinical significance. J Physiol Pharmacol.
67:801–817. 2016.PubMed/NCBI
|
|
133
|
Li SY, Chen C, Zhang HQ, Guo HY, Wang H,
Wang L, Zhang X, Hua SN, Yu J and Xiao PG: Identification of
natural compounds with antiviral activities against SARS-associated
coronavirus. Antiviral Res. 67:18–23. 2005.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Cui JD: Biotechnological production and
applications of Cordyceps militaris, a valued traditional
Chinese medicine. Crit Rev Biotechnol. 35:475–484. 2015.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Ashraf SA, Elkhalifa AE, Siddiqui AJ,
Patel M, Awadelkareem AM, Snoussi M, Ashraf MS, Adnan M and Hadi S:
Cordycepin for health and wellbeing: A Potent bioactive metabolite
of an entomopathogenic cordyceps medicinal fungus and its
nutraceutical and therapeutic potential. Molecules.
25(2735)2020.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Daba G: The endless nutritional and
pharmaceutical benefits of the Himalayan gold, Cordyceps;
Current knowledge and prospective potentials. Biofarmasi J Nat Prod
Biochem. 18:70–77. 2020.
|
|
137
|
Yang M, Shang YX, Tian ZY, Xiong M, Lu CL,
Jiang Y, Zhang Y, Zhang YY, Jin XY, Jin QB, et al: Characteristics
of registered studies for Coronavirus disease 2019 (COVID-19): A
systematic review. Integr Med Res. 9(100426)2020.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Boone HA, Medunjanin D and Sijerčić A:
Review on potential of phytotherapeutics in fight against COVID-19.
Int J Innov Sci Res Technol. 5:481–491. 2020.
|
|
139
|
Suwannarach N, Kumla J, Sujarit K,
Pattananandecha T, Saenjum C and Lumyong S: Natural bioactive
compounds from fungi as potential candidates for protease
inhibitors and immunomodulators to apply for coronaviruses.
Molecules. 25(1800)2020.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Umesh Kundu D, Selvaraj C, Singh SK and
Dubey VK: Identification of new anti-nCoV drug chemical compounds
from Indian spices exploiting SARS-CoV-2 main protease as target. J
Biomol Struct Dyn. 1–9. 2020.doi: 10.1080/07391102.2020.1763202
(Epub ahead of print). PubMed/NCBI View Article : Google Scholar
|
|
141
|
Paintsil E and Cheng YC: Antiviral agents.
Encyclopedia Microbiology. 176–225. 2019.doi:
10.1016/B978-0-12-801238-3.02387-4.
|
|
142
|
Xing Y, Mo P, Xiao Y, Zhao O, Zhang Y and
Wang F: Post-discharge surveillance and positive virus detection in
two medical staff recovered from coronavirus disease 2019
(COVID-19), China, January to February 2020. Euro Surveill.
25(2000191)2020.PubMed/NCBI View Article : Google Scholar
|
